Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing 8 (MFSD8) is a lysosomal membrane protein predicted to function as a solute transporter. The precise transported substrate is unknown. Mutations in the MFSD8 gene cause variant late-infantile neuronal ceroid lipofuscinosis (vLINCL, CLN7), a severe neurodegenerative lysosomal storage disorder. MFSD8 localizes primarily to neurons and astrocytes and participates in lysosomal and autophagic pathways, contributing to neuronal health. Recent studies indicate rare variants may also increase risk for adult neurodegenerative diseases like frontotemporal dementia. No current drugs directly target MFSD8, but the gene and protein serve as key diagnostic and research markers for NCL and related neurodegenerative disorders
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing 8 (MFSD8).